Patton Fund Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-732
Closed -$214K 214
2026
Q1
$214K Buy
+732
New +$241K 0.04% 451
2025
Q4
Sell
-685
Closed -$221K 478
2025
Q3
$221K Buy
+685
New +$213K 0.04% 376
2023
Q1
Sell
-402
Closed -$206K 133
2022
Q4
$206K Buy
+402
New +$204K 0.06% 160
2019
Q3
Sell
-7,425
Closed -$2.1M 82
2019
Q2
$2.1M Buy
+7,425
New +$2.03M 0.83% 51

Other funds holding ELV

Patton Fund Management's ELV Position: Q2 2026 in Review

Patton Fund Management sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 732 shares — an estimated $214K sold.

Patton Fund Management first reported a position in ELV in Q2 2019 and held it in 4 quarters. The position peaked at $2.1M in Q2 2019. 591 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Patton Fund Management reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Patton Fund Management sold 732 Elevance Health shares in Q2 2026, an estimated $214K.
  • Patton Fund Management first reported a position in Elevance Health in Q2 2019 and held it in 4 quarters.
  • Patton Fund Management's Elevance Health position peaked at $2.1M in Q2 2019.
  • 591 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Patton Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.